---
title: "Tirzepatide (Zepbound) in Pregnancy and Breastfeeding"
description: "This page reviews tirzepatide (Zepbound) in pregnancy and breastfeeding, including animal teratogenicity data and the FDA pregnancy registry."
url: https://healthrx.com/zepbound/pregnancy-lactation
publisher: HealthRX.com
---


HealthRX.com

Label says stop Zepbound when pregnancy is recognized

[Print or save as PDF](https://healthrx.com/printables/zepbound/pregnancy-lactation?print=1)

Key numbers

- 0.02% Total drug in milk over 28 days from samples with measurable drug, as share of maternal dose Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b), as cited Nov 7, 2026
- 4 weeks Time on a barrier method after starting Zepbound or each dose increase, for women using oral contraceptives Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b), as cited Nov 7, 2026
- approximately 5 days Tirzepatide half-life, which indicates how long the drug lingers in the body after stopping Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b), as cited Nov 7, 2026

From the public record

Pregnancy and breast feeding mentions in Zepbound reports

Zepbound has 550 reports with a pregnancy or breastfeeding term out of 80,835, or 0.68%, well under the 1.6% across all medicines. Maternal exposure during pregnancy accounts for 504 of them, and 14 name exposure while breast feeding. Yearly counts of 60, 208 and 282 show how reports accumulate, not a pregnancy risk.

Pregnancy and breast feeding mentions in Zepbound reports: the figures

| Measure | Value | Note |
| --- | --- | --- |
| Reports naming at least one pregnancy or breastfeeding term | 550 |  |
| Share of all reports for Zepbound | 0.68% | of 80,835 reports |
| Same terms across every medicine in FAERS | 1.6% | share of all reports in the database, for context |
| Maternal exposure during pregnancy | 504 reports |  |
| Abortion spontaneous | 63 reports |  |
| Foetal exposure during pregnancy | 17 reports |  |
| Maternal exposure during breast feeding | 14 reports |  |
| Exposure during pregnancy | 7 reports |  |

Source: [FDA Adverse Event Reporting System (FAERS) via openFDA](https://open.fda.gov/data/faers/), data as of Oct 28, 2026

How this was calculated

Searched the FAERS records for Zepbound and kept those containing any of 26 pregnancy or breastfeeding terms. The leading terms were then counted alone and the matches grouped by year received. A report may hold several terms and cannot show the drug caused anything.

Scope: Zepbound reports naming any of 26 pregnancy or breastfeeding terms, 2024 to 2026-10-28

HealthRX.com quick answer. Zepbound is not listed as contraindicated in pregnancy, but the label says weight loss offers no benefit to a pregnant patient and may cause fetal harm, and that Zepbound should be discontinued when a pregnancy is recognized [1]. Human pregnancy data are insufficient to evaluate the risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes [1]. On lactation, a single 5 mg dose given to 11 breastfeeding women produced milk concentrations that were undetectable in 164 of 171 samples, though the label says there are no available data on tirzepatide's effects on the breastfed infant or on milk production, and that breastfeeding benefits should be considered alongside the mother's clinical need for Zepbound and any potential adverse effects on the breastfed infant [1].

At a glance

- Pregnancy in the label / Not a contraindication; may cause fetal harm, discontinue when pregnancy is recognized [1]
- Human pregnancy data / Insufficient to evaluate risk of major birth defects, miscarriage or other outcomes [1]
- Label contraindications / Personal or family history of MTC or MEN 2; serious hypersensitivity [1]
- Breast milk study / Single 5 mg dose in 11 lactating women; undetectable in 164 of 171 samples [1]
- Remaining milk samples / Cumulative amount less than 0.02% of the maternal dose over 28 days [1]
- Oral contraceptives / Switch to a non-oral method or add a barrier method for 4 weeks after starting and after each dose escalation [1]
- Pregnancy registry / 1-844-524-0039 or [MILEregistry@thermofisher.com](mailto:MILEregistry@thermofisher.com) [1]

## Is Zepbound contraindicated in pregnancy?

Pregnancy is not one of the two contraindications in the Zepbound label. Those are a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and a known serious hypersensitivity to tirzepatide or any of the excipients in Zepbound [1].

Pregnancy is addressed instead in the Use in Specific Populations section, where the label states that weight loss offers no benefit to a pregnant patient and may cause fetal harm, and advises discontinuing Zepbound when a pregnancy is recognized [1]. The label's one-line summary of that section reads: may cause fetal harm, and when pregnancy is recognized, discontinue Zepbound [1].

Tirzepatide is a dual GIP and GLP-1 receptor agonist given once weekly by subcutaneous injection [1].

What people on Reddit report

These are Zepbound users and parents discussing whether the drug counts as contraindicated in pregnancy, and why. Some say the label is cautious about testing, while others say weight loss itself is the concern.

Ok-Yam-3358 · Zepbound

The one implies there isn't an actual safety issue and Lilly was just overly cautious in their testing protocols. The other implies that there may be an actual danger related to the med in pregnancy.

Commenter argues that the wording of the pregnancy warning matters, because a reader could take it as a minor testing issue rather than a possible safety problem.

[Read the source discussion](https://www.reddit.com/r/Zepbound/comments/1kliul0/pregnancy/)

Ok-Yam-3358 · Zepbound

It's not contraindicated just because they don't test pregnant people. It's also contraindicated because weight loss during pregnancy is bad for fetal development.

Commenter says the warning is about the effect of weight loss on the fetus, not only the lack of testing in pregnant people.

[Read the source discussion](https://www.reddit.com/r/Zepbound/comments/1kliul0/pregnancy/)

Karinka_LI · Zepbound

Zepbound is contraindicated only because they don't test drugs in pregnant people. You should definately stop but don't get too worried.

Commenter, who reports having heard of no bad outcomes, says the warning comes from missing pregnancy testing and advises stopping the drug.

[Read the source discussion](https://www.reddit.com/r/Zepbound/comments/1kliul0/pregnancy/)

Ok-Yam-3358 · Zepbound

That said, as you indicated, when Zepbound is discontinued immediately, we have many reports of healthy/happy babies.

Commenter reports many healthy births when the drug was stopped right away after a pregnancy was recognized.

[Read the source discussion](https://www.reddit.com/r/Zepbound/comments/1kliul0/pregnancy/)

Questions worth asking

Choose the questions you want to keep Should I stop Zepbound right away if I find out I am pregnant? Why does the label say weight loss is not recommended during pregnancy? What weight gain is appropriate for me during pregnancy while on or off Zepbound? Do I need a non-oral or barrier birth control method after restarting Zepbound? Is there a pregnancy registry I can enroll in if I was exposed to Zepbound? What should I know about breastfeeding before restarting Zepbound after birth?

## What human pregnancy data exist for tirzepatide?

Very little, and the label says so directly. Available data with tirzepatide in pregnant patients are insufficient to evaluate for a drug-related risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes [1].

The label describes a pregnancy exposure registry that monitors outcomes in women exposed to Zepbound during pregnancy, and encourages exposed patients and healthcare providers to register [1]. Registration is by phone at 1-844-524-0039 or by email at [MILEregistry@thermofisher.com](mailto:MILEregistry@thermofisher.com) [1].

## What did rat studies find for tirzepatide?

In pregnant rats given tirzepatide during organogenesis, fetal growth reductions and fetal abnormalities occurred at clinical exposures, according to the label [1]. In a rat pre- and postnatal development study, pups born to mothers given 0.25 mg/kg tirzepatide had statistically significantly lower mean body weight than controls from postnatal day 7 through postnatal day 126 for males, and through postnatal day 56 for females [1].

Based on the animal reproduction studies, the label says there may be risks to the fetus from exposure to tirzepatide during pregnancy [1].

## Can you breastfeed while taking Zepbound?

The label reports one human lactation study. Eleven healthy lactating women received a single 5 mg subcutaneous dose, and tirzepatide was undetectable in breast milk, at a limit of detection of 4 ng/mL, in 164 of 171 samples [1]. In the 7 samples with measurable drug, the cumulative amount over the 28-day sampling window was less than 0.02% of the maternal dose, the last measurable concentrations appeared 5 days after the dose, and the label notes that the AUC in breast milk could not be calculated [1].

The same section states that there are no available data on the effects of tirzepatide on the breastfed infant or on milk production [1]. The label says the developmental and health benefits of breastfeeding should be considered alongside the mother's clinical need for Zepbound and any potential adverse effects on the breastfed infant from Zepbound or from the underlying maternal condition [1].

That study measured one dose in 11 women, so it does not describe milk concentrations during weeks or months of weekly treatment.

## Does Zepbound reduce the effectiveness of birth control pills?

The label says use of Zepbound may reduce the efficacy of oral hormonal contraceptives because of delayed gastric emptying, a delay that is largest after the first dose and diminishes over time [1]. It advises patients using oral hormonal contraceptives to switch to a non-oral method or add a barrier method for 4 weeks after starting Zepbound and for 4 weeks after each dose escalation, and says hormonal contraceptives not taken orally should not be affected [1].

The pharmacokinetic study described in the label used a single 5 mg tirzepatide dose with a combined oral contraceptive containing 0.035 mg ethinyl estradiol and 0.25 mg norgestimate [1]. Peak concentrations fell 59% for ethinyl estradiol, 66% for norgestimate and 55% for norelgestromin; total exposure (AUC) fell 20%, 21% and 23%; and time to peak was delayed by 2.5 to 4.5 hours [1].

## What does the label say about stopping Zepbound around pregnancy?

The label's instruction is to discontinue Zepbound when a pregnancy is recognized, and it advises pregnant patients that weight loss is not recommended during pregnancy [1]. For context on how long the drug stays in the body, tirzepatide's median time to peak concentration is 24 hours and its [half-life](https://healthrx.com/zepbound/pharmacokinetics) is approximately 5 days [1].

## How much weight returns after discontinuation?

In SURMOUNT-4, 783 adults received open-label tirzepatide 10 or 15 mg for 36 weeks, and the 670 who were randomized had a mean weight reduction of 20.9% [2]. From week 36 to week 88, mean weight change was -5.5% in those who stayed on tirzepatide and +14.0% in those switched to placebo, a difference of 19.4 percentage points [2].

Check what you know

Think you have it? Try 4 quick questions and see what the article says.

1. According to the article, is pregnancy one of the contraindications listed in the Zepbound label?

Question 1 of 4

Score: 0 right, 0 of 4 answered

Printable question sheet

Zepbound pregnancy and lactation visit questions

Use this sheet before or during a visit about Zepbound if you are planning a pregnancy, may be pregnant, are using birth control or are thinking about breastfeeding. Fill it in by hand and take it to your prescriber or pharmacist.

[Open the fill-in sheet](https://healthrx.com/printables/zepbound/pregnancy-lactation) Fill it in, print it or save it as a PDF. No sign-up.

Frequently asked questions

Is Zepbound safe to take during pregnancy?

The label does not list pregnancy as a contraindication, but it states that weight loss offers no benefit to a pregnant patient and may cause fetal harm, and advises discontinuing Zepbound when a pregnancy is recognized [1]. It also states that available data in pregnant patients are insufficient to evaluate a drug-related risk of major birth defects, miscarriage or other maternal or fetal outcomes [1].

Can you breastfeed while taking Zepbound?

In a single-dose study, 11 lactating women received 5 mg and tirzepatide was undetectable in 164 of 171 milk samples; the remaining samples totaled less than 0.02% of the maternal dose over 28 days [1]. The label says breastfeeding benefits should be considered alongside the mother's clinical need for Zepbound and any potential adverse effects on the breastfed infant [1].

How long do you need to stop Zepbound before getting pregnant?

The label's instruction is to discontinue Zepbound when a pregnancy is recognized [1]. Tirzepatide has a half-life of approximately 5 days [1].

What contraception does the label recommend on Zepbound?

For patients using oral hormonal contraceptives, the label advises switching to a non-oral method or adding a barrier method for 4 weeks after starting Zepbound and for 4 weeks after each dose escalation; hormonal contraceptives not taken orally should not be affected [1].

Is there a pregnancy registry for Zepbound?

Yes. The label describes a pregnancy exposure registry that monitors outcomes in women exposed to Zepbound during pregnancy and gives 1-844-524-0039 and MILEregistry@thermofisher.com for patients and clinicians to register [1].

Does Zepbound cause miscarriage?

The label states that available data in pregnant patients are insufficient to evaluate a drug-related risk of miscarriage or major birth defects [1]. In pregnant rats given tirzepatide during organogenesis, fetal growth reductions and fetal abnormalities occurred at clinical exposures [1].

References

Show all 3 references Hide references

1. U.S. National Library of Medicine, DailyMed. Zepbound injection (tirzepatide) prescribing information. [Zepbound injection (tirzepatide) label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
2. Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY, et al. [Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial](https://pubmed.ncbi.nlm.nih.gov/38078870/). JAMA. 2024;331(1):38-48.
3. Reddit participants. [Pregnancy (r/Zepbound)](https://www.reddit.com/r/Zepbound/comments/1kliul0/pregnancy/). Accessed 2026-11-10.

Next in this cluster

Related reading

- [tirzepatide Tirzepatide heart failure](https://healthrx.com/off-label-mounjaro/heart-failure--risks-tradeoffs)
- [tirzepatide Zepbound label updates](https://healthrx.com/regulatory-zepbound/label-updates)
- [tirzepatide Zepbound and Relationships](https://healthrx.com/lifestyle-zepbound/relationships)
- [tirzepatide Zepbound older adult safety](https://healthrx.com/zepbound/older-adult-safety)
- [tirzepatide Zepbound real-world evidence](https://healthrx.com/zepbound/real-world-evidence)
- [tirzepatide Zepbound regulatory status](https://healthrx.com/zepbound/regulatory-status-global)
- [tirzepatide Zepbound dosing in renal impairment](https://healthrx.com/zepbound/renal-impairment)
- [tirzepatide Zepbound Safety Signals & FDA Actions](https://healthrx.com/zepbound/safety-signals-fda)
- [tirzepatide Zepbound Self-Injection Technique](https://healthrx.com/zepbound/self-injection-technique)
- [tirzepatide Zepbound special populations](https://healthrx.com/zepbound/special-populations)
- [tirzepatide Zepbound storage](https://healthrx.com/zepbound/storage-stability)
- [tirzepatide Zepbound switching](https://healthrx.com/zepbound/switching-protocols)
- [tirzepatide Zepbound and sildenafil interaction](https://healthrx.com/interactions-zepbound/with-sildenafil)
- [side effects zepbound vomiting Zepbound vomiting](https://healthrx.com/side-effects-zepbound-vomiting/management-protocol)

![Zepbound pregnancy safety: pregnant woman discussing medication questions with her obstetrician in a clinic room](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/zepbound/pregnancy-lactation.webp)

Talking through medication plans with an obstetrician is the key step for anyone who is pregnant, trying to conceive, or breastfeeding. Full zepbound pregnancy guide and sources at [healthrx.com/zepbound](https://healthrx.com/zepbound).
